Covered recipient · General Payments record
JARED JAMES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2023
$610.27
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $288.69 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $109.29 | 6 |
| Novo Nordisk AS | $61.12 | 4 |
| PFIZER INC. | $29.80 | 2 |
| GlaxoSmithKline, LLC. | $27.62 | 2 |
| Abbott Laboratories | $18.52 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.00 | 1 |
| Amgen Inc. | $13.75 | 1 |
| Lundbeck LLC | $13.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.52 | 07/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018500589 | CMS |
| ABBVIE INC. | $14.37 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997553973 | CMS |
| ABBVIE INC. | $13.47 | 07/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997553975 | CMS |
| ABBVIE INC. | $14.35 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997553977 | CMS |
| ABBVIE INC. | $23.68 | 10/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997553979 | CMS |
| ABBVIE INC. | $17.06 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997553981 | CMS |
| ABBVIE INC. | $26.36 | 12/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997553983 | CMS |
| Amgen Inc. | $13.75 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020595279 | CMS |
| GlaxoSmithKline, LLC. | $14.73 | 09/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002956005 | CMS |
| GlaxoSmithKline, LLC. | $12.89 | 10/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002955993 | CMS |
| Lundbeck LLC | $13.59 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032250629 | CMS |
| Novo Nordisk Inc | $14.42 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002583009 | CMS |
| Novo Nordisk Inc | $15.04 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002583025 | CMS |
| Novo Nordisk Inc | $15.41 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002583039 | CMS |
| Novo Nordisk Inc | $16.25 | 10/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002583051 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.00 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014434995 | CMS |
| PFIZER INC. | $13.28 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049279317 | CMS |
| PFIZER INC. | $16.52 | 12/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050213797 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.